Brief Article
Copyright ©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 28, 2011; 17(4): 488-492
Published online Jan 28, 2011. doi: 10.3748/wjg.v17.i4.488
Table 1 Associations between EGF +61A/G variants and clinicopathological parameters in patients with gastric lesions1n (%)
CasesControlsOR (95% CI)P
Gastric lesions1 (n = 207)
Genotypes
GG38 (18.4)231 (23.5)1
GA104 (50.2)449 (45.6)1.41 (0.92-2.15)0.096
AA65 (31.4)304 (30.9)1.30 (0.82-2.06)0.237
GA + AA169 (68.6)753 (76.5)1.36 (0.92-2.04)0.109
Atrophy or intestinal metaplasia (n = 45)
Genotypes
GG9 (20.0)231 (23.5)1
GA20 (44.4)449 (45.6)1.44 (0.49-2.76)0.743
AA16 (35.6)304 (30.9)1.35 (0.55-3.37)0.478
GA + AA36 (80.0)753 (76.5)1.23 (0.56-2.78)0.590
Gastric adenocarcinoma (n = 162)
Genotypes
GG29 (17.9)231 (23.5)1
GA84 (51.9)449 (45.6)1.49 (0.93-2.40)0.082
AA49 (30.2)304 (30.9)1.28 (0.77-2.16)0.317
GA + AA133 (82.1)753 (76.5)1.41 (0.90-2.21)0.116